Acute lymphoblastic leukaemia trials in Germany

In Germany 35 Also abroad 564

35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Enrolling by invitation
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
Where
Berlin, Dresden, Marburg, Munich, Ulm
Age
18 years and over
People
178
Run by
AvenCell Therapeutics, Inc.
See details and how to joinNCT07474051 · EU 2025-521717-67-00
Phase 1/2Taking people
Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
Where
Berlin, Duesseldorf, Essen, Frankfurt Am Main, Freiburg, Hamburg, Hannover, Kiel, München, Tuebingen, Ulm, Wuerzburg
Age
3 years to 18 years
People
20
Run by
University Hospital Tuebingen
See details and how to joinNCT05366218 · EU 2024-511336-28-00
No phaseTaking people
Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy
Where
Erlangen
Age
3 years to 17 years
People
30
Run by
University of Erlangen-Nürnberg Medical School
See details and how to joinNCT07313878
Phase 1/2Taking people
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Where
Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00
Phase 1/2Taking people
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01
Phase 1/2Taking people
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00
Phase 2Taking people
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Where
Aachen, Aschaffenburg, Augsburg, Bad Saarow, Bayreuth, Berlin, Bielefeld, Bochum, Bonn, Bremen, Brunswick, Chemnitz, Cologne, Cottbus, Darmstadt, Dessau-Rosslau, Dortmund, Dresden, Duesseldorf, Duisburg, Erlangen, Eschweiler, Essen, Frankfurt Am Main, Freiburg im Breisgau, Fulda, Georgsmarienhuette, Goch, Goettingen, Greifswald, Guetersloh, Hagen, Halle (Saale), Hamburg, Hamm, Hannover, Hanover, Heidelberg, Herne, Homburg, Idar-Oberstein, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Luedenscheid, Magdeburg, Mainz, Mannheim, Marburg, Meschede, Moenchengladbach, Muenster, Munich, Nuremberg, Offenburg, Oldenburg, Paderborn, Passau, Potsdam, Regensburg, Rostock, Schwaebisch Hall, Stuttgart, Traunstein, Trier, Tuebingen, Ulm, Villingen-Schwenningen, Wuerzburg, Wuppertal, Zwickau
Age
18 years to 65 years
People
220
Run by
Goethe University
See details and how to joinNCT06061094 · EU 2024-517966-40-00
Phase 3Taking people
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Where
Aachen, Augsburg, Berlin, Brunswick, Chemnitz, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle (Saale), Hanover, Heidelberg, Heilbronn, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Luebeck, Magdeburg, Mannheim, Minden, Muenster, Munich, Nuernberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wolfsburg, Wuerzburg
Age
Up to 17 years
People
5,000 worldwide
Run by
Martin Schrappe
See details and how to joinNCT03643276 · EU 2023-509856-32-00
No phaseTaking people
Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians
Where
München
Age
8 years to 14 years
People
60
Run by
Deutsches Herzzentrum Muenchen
See details and how to joinNCT06626672
Phase 1/2Taking people
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Where
Heidelberg
Age
3 years and over
People
68
Run by
University Hospital Heidelberg
See details and how to joinNCT03676504 · EU 2024-516832-82-00